Altered nigrostriatal dopaminergic and noradrenergic system prompted by systemic lead toxicity versus a treatment by curcumin-III in the desert rodent Meriones shawi.
Administration, Oral
Animals
Corpus Striatum
/ pathology
Curcumin
/ analogs & derivatives
Dopaminergic Neurons
/ drug effects
Gerbillinae
Lead Poisoning, Nervous System
/ drug therapy
Locus Coeruleus
/ pathology
Male
Movement Disorders
/ psychology
Neuroprotective Agents
/ therapeutic use
Parasympathetic Nervous System
/ pathology
Substantia Nigra
/ pathology
Ventral Tegmental Area
/ pathology
Curcumin-III
Dopamine and noradrenaline
Lead neurotoxicity
Locomotion
Meriones shawi
Midbrain
Journal
Comptes rendus biologies
ISSN: 1768-3238
Titre abrégé: C R Biol
Pays: France
ID NLM: 101140040
Informations de publication
Date de publication:
Historique:
received:
13
06
2019
revised:
15
07
2019
accepted:
16
07
2019
pubmed:
3
9
2019
medline:
24
12
2019
entrez:
3
9
2019
Statut:
ppublish
Résumé
Exposure to lead is a threat factor for neurodegenerative disorders progress as it could trigger dopaminergic deficiency. We aimed herein to assess the effect of acute lead exposure (25mg/kg B.W i.p.) during three continuous days on the dopaminergic and noradrenergic systems together with locomotor performance in Meriones shawi (M. shawi), then the neuroprotective potential of curcumin-III (30mg/kg B.W) by oral gavage. Pb-exposed M. shawi exhibited increased tyrosine hydroxylase (TH) immunoreactivity in substantia nigra compacta (SNc), ventral tegmental area (VTA), locus coeruleus (LC), and dorsal striatum (DS), unlike the controls. This was correlated with decreased locomotor performance. A noticeable protective effect by co-treatment with curcumin-III was observed; in consequence, TH-immunoreactivity and locomotor disturbance were restored in Pb-treated Meriones. Our data results proved, on the one hand, an evident neurotoxic effect of acute Pb exposure and, on the other hand, a potent therapeutic effect of curcumin-III. Thereby, this compound may be recommended as a neuroprotective molecule for neurodegenerative disorders involving catecholaminergic impairment initiated by metallic elements.
Identifiants
pubmed: 31474522
pii: S1631-0691(19)30066-6
doi: 10.1016/j.crvi.2019.07.004
pii:
doi:
Substances chimiques
Neuroprotective Agents
0
curcumin III
33171-05-0
Curcumin
IT942ZTH98
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
192-198Informations de copyright
Copyright © 2019. Published by Elsevier Masson SAS.